DNAJB12
geneOn this page
Also known as DJ10FLJ20027
Summary
DNAJB12 (DnaJ heat shock protein family (Hsp40) member B12, HGNC:14891) is a protein-coding gene on chromosome 10q22.1, encoding DnaJ homolog subfamily B member 12 (Q9NXW2). Acts as a co-chaperone with HSPA8/Hsc70; required to promote protein folding and trafficking, prevent aggregation of client proteins, and promote unfolded proteins to endoplasmic reticulum-associated degradation (ERAD) pathway.
DNAJB12 belongs to the evolutionarily conserved DNAJ/HSP40 family of proteins, which regulate molecular chaperone activity by stimulating ATPase activity. DNAJ proteins may have up to 3 distinct domains: a conserved 70-amino acid J domain, usually at the N terminus; a glycine/phenylalanine (G/F)-rich region; and a cysteine-rich domain containing 4 motifs resembling a zinc finger domain (Ohtsuka and Hata, 2000 [PubMed 11147971]).
Source: NCBI Gene 54788 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 74 total
- Druggable target: yes
- MANE Select transcript:
NM_017626
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14891 |
| Approved symbol | DNAJB12 |
| Name | DnaJ heat shock protein family (Hsp40) member B12 |
| Location | 10q22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DJ10, FLJ20027 |
| Ensembl gene | ENSG00000148719 |
| Ensembl biotype | protein_coding |
| OMIM | 608376 |
| Entrez | 54788 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 10 protein_coding, 1 retained_intron
ENST00000338820, ENST00000394903, ENST00000444643, ENST00000461919, ENST00000463786, ENST00000473051, ENST00000876766, ENST00000876767, ENST00000876768, ENST00000926394, ENST00000967016
RefSeq mRNA: 4 — MANE Select: NM_017626
NM_001002762, NM_001365080, NM_001365081, NM_017626
CCDS: CCDS7316
Canonical transcript exons
ENST00000444643 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000986997 | 72344950 | 72345127 |
| ENSE00001519957 | 72335780 | 72335931 |
| ENSE00001884528 | 72354765 | 72354919 |
| ENSE00001901147 | 72332863 | 72334617 |
| ENSE00003679224 | 72343366 | 72343511 |
| ENSE00003702617 | 72340789 | 72340868 |
| ENSE00003705590 | 72336524 | 72336696 |
| ENSE00003706955 | 72340985 | 72341170 |
| ENSE00003707848 | 72338202 | 72338311 |
Expression profiles
Bgee: expression breadth ubiquitous, 290 present calls, max score 93.44.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 42.1981 / max 244.2389, expressed in 1821 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 110005 | 28.2257 | 1821 |
| 110007 | 11.1300 | 1791 |
| 110006 | 2.5663 | 1585 |
| 110002 | 0.1625 | 54 |
| 110003 | 0.1136 | 51 |
Top tissues by expression
295 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| tongue squamous epithelium | UBERON:0006919 | 93.44 | gold quality |
| diaphragm | UBERON:0001103 | 93.27 | silver quality |
| type B pancreatic cell | CL:0000169 | 93.07 | gold quality |
| gluteal muscle | UBERON:0002000 | 92.15 | gold quality |
| triceps brachii | UBERON:0001509 | 92.05 | gold quality |
| olfactory bulb | UBERON:0002264 | 91.63 | silver quality |
| tibial nerve | UBERON:0001323 | 91.54 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 91.37 | gold quality |
| left adrenal gland | UBERON:0001234 | 91.20 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 91.19 | gold quality |
| right adrenal gland | UBERON:0001233 | 91.14 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 91.06 | gold quality |
| gastrocnemius | UBERON:0001388 | 91.02 | gold quality |
| monocyte | CL:0000576 | 90.82 | gold quality |
| mononuclear cell | CL:0000842 | 90.80 | gold quality |
| leukocyte | CL:0000738 | 90.78 | gold quality |
| granulocyte | CL:0000094 | 90.76 | gold quality |
| muscle of leg | UBERON:0001383 | 90.69 | gold quality |
| adrenal cortex | UBERON:0001235 | 90.63 | gold quality |
| male germ cell | CL:0000015 | 90.50 | gold quality |
| sperm | CL:0000019 | 90.23 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 90.22 | gold quality |
| muscle organ | UBERON:0001630 | 90.19 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 90.16 | gold quality |
| adrenal gland | UBERON:0002369 | 90.16 | gold quality |
| minor salivary gland | UBERON:0001830 | 90.06 | gold quality |
| skin of leg | UBERON:0001511 | 89.98 | gold quality |
| apex of heart | UBERON:0002098 | 89.92 | gold quality |
| renal glomerulus | UBERON:0000074 | 89.87 | gold quality |
| body of stomach | UBERON:0001161 | 89.85 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 9.57 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): KDM5B
miRNA regulators (miRDB)
121 targeting DNAJB12, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-4692 | 100.00 | 67.32 | 2066 |
| HSA-MIR-3064-3P | 100.00 | 70.09 | 1254 |
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-6127 | 100.00 | 66.76 | 2188 |
| HSA-MIR-6129 | 100.00 | 66.46 | 2080 |
| HSA-MIR-5193 | 100.00 | 67.26 | 1744 |
| HSA-MIR-4510 | 100.00 | 66.60 | 2050 |
| HSA-MIR-6130 | 100.00 | 66.69 | 2012 |
| HSA-MIR-6133 | 100.00 | 66.48 | 2064 |
| HSA-MIR-4514 | 99.99 | 67.10 | 1870 |
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-32-5P | 99.98 | 75.21 | 1964 |
| HSA-MIR-92A-3P | 99.98 | 75.21 | 1960 |
| HSA-MIR-92B-3P | 99.98 | 75.25 | 1955 |
| HSA-MIR-25-3P | 99.98 | 74.60 | 1817 |
| HSA-MIR-363-3P | 99.98 | 74.72 | 1821 |
| HSA-MIR-367-3P | 99.98 | 74.83 | 1819 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-4725-3P | 99.96 | 69.53 | 2520 |
| HSA-MIR-6780B-5P | 99.96 | 69.60 | 2562 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-2110 | 99.96 | 66.68 | 1930 |
| HSA-MIR-8082 | 99.95 | 67.27 | 1170 |
| HSA-MIR-4493 | 99.90 | 66.48 | 977 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
Literature-anchored findings (GeneRIF, showing 6)
- JB12 cooperates with cytosolic Hsc70 and the ubiquitin ligase RMA1 to target CFTR and CFTRDeltaF508 for degradation. (PMID:21148293)
- DNAJB12 is a novel mammalian ER-localized J-protein that plays a vital role in the quality control of membrane proteins (PMID:21150129)
- Over-expression of DNAJB12 or DNAJB14 causes the formation of elaborate membranous structures within cell nuclei, designated DJANGOS for DNAJ-associated nuclear globular structures. (PMID:24732912)
- ER-located J-protein chaperones were identified as key regulators for the iogenesis and physiological function of ERG K+ channels. They regulate two distinct aspects of K+ channel biogenesis, the stabilization and assembly of channel subunits. (PMID:27916661)
- Data suggest that endoplasmic reticulum (ER) stress-induced apoptosis in hepatoma cells is regulated by highly labile and ER-associated BCL-2 family member BOK, which is controlled at level of protein stability by ER-associated degradation components; DNAJB12 is required in hepatoma cells to maintain BOK at low levels and suppress ER stress. (DNAJB12 = DnaJ (Hsp40) homolog, subfamily B, member 12) (PMID:28536268)
- DNAJB12 and DNJB14 are non-redundant Hsp40 redox chaperones involved in endoplasmic reticulum protein reflux. (PMID:37925033)
Cross-species orthologs
11 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | dnajb12a | ENSDARG00000039363 |
| danio_rerio | dnajb12b | ENSDARG00000087473 |
| mus_musculus | Dnajb12 | ENSMUSG00000020109 |
| rattus_norvegicus | Dnajb12 | ENSRNOG00000030408 |
| drosophila_melanogaster | CG2887 | FBGN0030207 |
| drosophila_melanogaster | CG5001 | FBGN0031322 |
| drosophila_melanogaster | CG3061 | FBGN0038195 |
| drosophila_melanogaster | CG30156 | FBGN0050156 |
| drosophila_melanogaster | DnaJ-1 | FBGN0263106 |
| caenorhabditis_elegans | WBGENE00001019 | |
| caenorhabditis_elegans | WBGENE00001044 |
Paralogs (11): DNAJB11 (ENSG00000090520), DNAJB6 (ENSG00000105993), DNAJB9 (ENSG00000128590), DNAJB1 (ENSG00000132002), DNAJB2 (ENSG00000135924), DNAJB5 (ENSG00000137094), DNAJB4 (ENSG00000162616), DNAJB14 (ENSG00000164031), DNAJB7 (ENSG00000172404), DNAJB8 (ENSG00000179407), DNAJB13 (ENSG00000187726)
Protein
Protein identifiers
DnaJ homolog subfamily B member 12 — Q9NXW2 (reviewed: Q9NXW2)
All UniProt accessions (4): Q9NXW2, J3KPS0, V9GY70, V9GYN7
UniProt curated annotations — full annotation on UniProt →
Function. Acts as a co-chaperone with HSPA8/Hsc70; required to promote protein folding and trafficking, prevent aggregation of client proteins, and promote unfolded proteins to endoplasmic reticulum-associated degradation (ERAD) pathway. Acts by determining HSPA8/Hsc70’s ATPase and polypeptide-binding activities. Can also act independently of HSPA8/Hsc70: together with DNAJB14, acts as a chaperone that promotes maturation of potassium channels KCND2 and KCNH2 by stabilizing nascent channel subunits and assembling them into tetramers. While stabilization of nascent channel proteins is dependent on HSPA8/Hsc70, the process of oligomerization of channel subunits is independent of HSPA8/Hsc70. When overexpressed, forms membranous structures together with DNAJB14 and HSPA8/Hsc70 within the nucleus; the role of these structures, named DJANGOs, is still unclear. (Microbial infection) In case of infection by polyomavirus, involved in the virus endoplasmic reticulum membrane penetration and infection.
Subunit / interactions. Homodimer and homotetramer. Interacts (via J domain) with HSPA8/Hsc70. Forms a multiprotein complex, at least composed of DNAJB12, DNAJB14, HSPA8/Hsc70 and SGTA; interaction with DNAJB14 and HSPA8/Hsc70 is direct.
Subcellular location. Endoplasmic reticulum membrane. Nucleus membrane.
Post-translational modifications. Methylated at His-185 by METTL9.
Similarity. Belongs to the DnaJ family. DNAJB12/DNAJB14 subfamily.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9NXW2-1 | 1 | yes |
| Q9NXW2-2 | 2 |
RefSeq proteins (4): NP_001002762, NP_001352009, NP_001352010, NP_060096* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001623 | DnaJ_domain | Domain |
| IPR015399 | DUF1977_DnaJ-like | Domain |
| IPR018253 | DnaJ_domain_CS | Conserved_site |
| IPR036869 | J_dom_sf | Homologous_superfamily |
| IPR051100 | DnaJ_subfamily_B/C | Family |
Pfam: PF00226, PF09320
UniProt features (22 total): helix 4, mutagenesis site 3, sequence conflict 3, topological domain 2, modified residue 2, chain 1, sequence variant 1, turn 1, transmembrane region 1, domain 1, region of interest 1, compositionally biased region 1, splice variant 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 2CTP | SOLUTION NMR |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NXW2-F1 | 76.97 | 0.41 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 1, 185
Mutagenesis-validated functional residues (3):
| Position | Phenotype |
|---|---|
| 138 | abolishes interaction with hspa8/hsc70. |
| 184–212 | in delta(g/f); impaired ability to form tetramers and impaired ability to promote potassium channel assembly into tetram |
| 185 | abolished histidine methylation by mettl9. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 181 (showing top):
GOBP_RESPONSE_TO_NITROGEN_COMPOUND, FREAC2_01, TGCGCANK_UNKNOWN, GOBP_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS, MAZ_Q6, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, GOBP_CELLULAR_RESPONSE_TO_TOPOLOGICALLY_INCORRECT_PROTEIN, FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN, GOBP_PROTEIN_MATURATION, MODULE_379, WTGAAAT_UNKNOWN, FOXJ2_01, HNF4_DR1_Q3
GO Biological Process (4): protein folding (GO:0006457), ERAD pathway (GO:0036503), protein-containing complex assembly (GO:0065003), cellular response to misfolded protein (GO:0071218)
GO Molecular Function (1): Hsp70 protein binding (GO:0030544)
GO Cellular Component (5): endoplasmic reticulum (GO:0005783), endoplasmic reticulum membrane (GO:0005789), membrane (GO:0016020), nuclear membrane (GO:0031965), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular membrane-bounded organelle | 2 |
| organelle membrane | 2 |
| cellular process | 1 |
| protein maturation | 1 |
| proteasomal protein catabolic process | 1 |
| response to endoplasmic reticulum stress | 1 |
| response to chemical | 1 |
| cellular component assembly | 1 |
| protein-containing complex organization | 1 |
| cellular response to topologically incorrect protein | 1 |
| response to misfolded protein | 1 |
| heat shock protein binding | 1 |
| protein-folding chaperone binding | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| cellular anatomical structure | 1 |
| nucleus | 1 |
| nuclear envelope | 1 |
Protein interactions and networks
STRING
2437 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DNAJB12 | HSPA8 | P11142 | 750 |
| DNAJB12 | SGTA | O43765 | 724 |
| DNAJB12 | RNF5 | Q99942 | 630 |
| DNAJB12 | HSPH1 | Q92598 | 627 |
| DNAJB12 | TTC19 | Q6DKK2 | 606 |
| DNAJB12 | BLMH | Q13867 | 581 |
| DNAJB12 | EMC1 | Q8N766 | 532 |
| DNAJB12 | WDR73 | Q6P4I2 | 527 |
| DNAJB12 | BAG2 | O95816 | 524 |
| DNAJB12 | AMFR | P26442 | 476 |
| DNAJB12 | LYRM4 | Q9HD34 | 474 |
| DNAJB12 | RFFL | Q8WZ73 | 471 |
| DNAJB12 | USP37 | Q86T82 | 468 |
| DNAJB12 | HSPA4 | P34932 | 464 |
| DNAJB12 | MORF4L1 | Q9UBU8 | 452 |
IntAct
76 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CFTR | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.710 |
| CFTR | ESYT2 | psi-mi:“MI:0914”(association) | 0.710 |
| CFTR | HAX1 | psi-mi:“MI:0914”(association) | 0.610 |
| RPN1 | APBB1 | psi-mi:“MI:0914”(association) | 0.530 |
| ALK | PIK3R2 | psi-mi:“MI:0914”(association) | 0.420 |
| CABYR | DNAJB12 | psi-mi:“MI:0915”(physical association) | 0.400 |
| psi-mi:“MI:0914”(association) | 0.350 | ||
| E5 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| MAPK6 | psi-mi:“MI:0914”(association) | 0.350 | |
| RIPK4 | VWA8 | psi-mi:“MI:0914”(association) | 0.350 |
| PB1 | HAX1 | psi-mi:“MI:0914”(association) | 0.350 |
| PB1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| PB1 | psi-mi:“MI:0914”(association) | 0.350 | |
| PB2 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| MME | psi-mi:“MI:0914”(association) | 0.350 | |
| Mecom | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| APP | MGST3 | psi-mi:“MI:0914”(association) | 0.350 |
| PSEN1 | PGRMC1 | psi-mi:“MI:0914”(association) | 0.350 |
| CD74 | psi-mi:“MI:0914”(association) | 0.350 | |
| P2RY6 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC15A3 | psi-mi:“MI:0914”(association) | 0.350 | |
| UNC93B1 | psi-mi:“MI:0914”(association) | 0.350 | |
| P2RY6 | psi-mi:“MI:0914”(association) | 0.350 | |
| P2RY6 | RAVER1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (233): HSPA2 (Co-fractionation), HSPA8 (Co-fractionation), HSPA9 (Co-fractionation), DNAJB12 (Affinity Capture-MS), DNAJB12 (Affinity Capture-MS), DNAJB12 (Affinity Capture-RNA), DNAJB12 (Affinity Capture-MS), DNAJB12 (Affinity Capture-MS), DNAJB12 (Biochemical Activity), DNAJB12 (Affinity Capture-MS), DNAJB12 (Affinity Capture-MS), DNAJB12 (Affinity Capture-MS), DNAJB12 (Affinity Capture-MS), DNAJB12 (Affinity Capture-MS), DNAJB12 (Affinity Capture-MS)
ESM2 similar proteins: A0A0D1E2P6, A0A0D2XVZ5, A0A0P0VG31, A0A0P1AAU8, A0A287B8J2, A2WYG9, A4QP73, B9EHT4, B9F2Y7, D0NCC1, J9VKM5, O08788, O59739, P0C7L7, P0CP26, P0CP27, P14725, P28023, P39742, P82874, P92792, Q10MW6, Q13217, Q14203, Q149L6, Q27968, Q28I38, Q54M21, Q54NS3, Q58DR2, Q5JJI4, Q5JNB5, Q5R686, Q5R6H3, Q5ZI13, Q6PCJ1, Q6YUL8, Q7ZXQ8, Q8TBM8, Q91YW3
Diamond homologs: A0LJ41, A1V9Q3, A1WAR7, A1WX30, A2ALW5, A3DF24, A4IR30, A5ITA7, A5WBF8, A6QHC2, A6U251, A7GT07, A7X2Y0, A7Z6W0, A8FFD1, A8Z4B8, A9KE65, A9NDK6, A9VHU0, B0JW23, B0VQ00, B1HUD0, B1WVR2, B1Y787, B1YKT0, B2GBQ6, B2I2G6, B2J3J3, B3EE31, B7GV08, B7HPL2, B7I2B2, B7JN38, B8CXL0, B8FUN3, B9DNJ9, B9IY80, C1ESK7, C3L5R6, C3P8L9
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| DNAJB12 | “up-regulates activity” | HSPA8 | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 87 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | 5 | 28.0× | 4e-04 |
| Maturation of spike protein | 5 | 22.1× | 6e-04 |
| Maturation of DENV proteins | 5 | 17.6× | 9e-04 |
| MAPK6/MAPK4 signaling | 5 | 11.3× | 6e-03 |
| Interleukin-1 signaling | 5 | 10.3× | 7e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
74 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 58 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1389 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:72335932:C:CC | acceptor_gain | 1.0000 |
| 10:72336520:TCA:T | donor_loss | 1.0000 |
| 10:72336521:CACT:C | donor_loss | 1.0000 |
| 10:72336522:A:AC | donor_gain | 1.0000 |
| 10:72336522:ACT:A | donor_gain | 1.0000 |
| 10:72336522:ACTC:A | donor_loss | 1.0000 |
| 10:72336523:C:CT | donor_gain | 1.0000 |
| 10:72336523:CT:C | donor_gain | 1.0000 |
| 10:72336523:CTC:C | donor_gain | 1.0000 |
| 10:72336523:CTCT:C | donor_gain | 1.0000 |
| 10:72336523:CTCTG:C | donor_gain | 1.0000 |
| 10:72336539:T:TA | donor_gain | 1.0000 |
| 10:72336642:A:C | acceptor_gain | 1.0000 |
| 10:72336702:C:T | acceptor_gain | 1.0000 |
| 10:72338201:CGGT:C | donor_gain | 1.0000 |
| 10:72340983:A:AC | donor_gain | 1.0000 |
| 10:72340984:C:CA | donor_gain | 1.0000 |
| 10:72340984:CT:C | donor_gain | 1.0000 |
| 10:72340984:CTA:C | donor_gain | 1.0000 |
| 10:72340984:CTAG:C | donor_gain | 1.0000 |
| 10:72340984:CTAGA:C | donor_gain | 1.0000 |
| 10:72341166:AATGG:A | acceptor_gain | 1.0000 |
| 10:72341167:ATGG:A | acceptor_gain | 1.0000 |
| 10:72341167:ATGGC:A | acceptor_gain | 1.0000 |
| 10:72341168:TGG:T | acceptor_gain | 1.0000 |
| 10:72341168:TGGC:T | acceptor_gain | 1.0000 |
| 10:72341169:GG:G | acceptor_gain | 1.0000 |
| 10:72341169:GGC:G | acceptor_gain | 1.0000 |
| 10:72341170:GC:G | acceptor_gain | 1.0000 |
| 10:72341171:C:CA | acceptor_loss | 1.0000 |
AlphaMissense
2473 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:72335850:C:G | C363S | 1.000 |
| 10:72335850:C:T | C363Y | 1.000 |
| 10:72335851:A:G | C363R | 1.000 |
| 10:72335851:A:T | C363S | 1.000 |
| 10:72335910:G:T | A343E | 1.000 |
| 10:72335911:C:G | A343P | 1.000 |
| 10:72336543:G:C | C329W | 1.000 |
| 10:72336544:C:A | C329F | 1.000 |
| 10:72336544:C:G | C329S | 1.000 |
| 10:72336544:C:T | C329Y | 1.000 |
| 10:72336545:A:G | C329R | 1.000 |
| 10:72336545:A:T | C329S | 1.000 |
| 10:72336553:C:G | R326P | 1.000 |
| 10:72336556:A:G | L325P | 1.000 |
| 10:72338268:A:T | L256Q | 1.000 |
| 10:72338280:G:C | P252R | 1.000 |
| 10:72338280:G:T | P252H | 1.000 |
| 10:72341004:A:C | F208L | 1.000 |
| 10:72341004:A:T | F208L | 1.000 |
| 10:72341006:A:G | F208L | 1.000 |
| 10:72341006:A:T | F208I | 1.000 |
| 10:72341007:G:C | F207L | 1.000 |
| 10:72341007:G:T | F207L | 1.000 |
| 10:72341008:A:G | F207S | 1.000 |
| 10:72341009:A:G | F207L | 1.000 |
| 10:72341016:G:C | F204L | 1.000 |
| 10:72341016:G:T | F204L | 1.000 |
| 10:72341017:A:C | F204C | 1.000 |
| 10:72341017:A:G | F204S | 1.000 |
| 10:72341018:A:G | F204L | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000016676 (10:72335138 A>G), RS1000248148 (10:72334687 A>G), RS1000339441 (10:72346708 A>C,G,T), RS1000487019 (10:72337297 T>C), RS1000612763 (10:72353689 G>A,C), RS1000774514 (10:72337515 G>A), RS1000821776 (10:72335996 C>G,T), RS1000857383 (10:72347011 C>A,T), RS1000910146 (10:72342021 G>A), RS1001010148 (10:72347862 G>A), RS1001093841 (10:72347691 G>A), RS1001133019 (10:72354621 C>T), RS1001258842 (10:72340524 G>C,T), RS1001354624 (10:72346626 A>C), RS1001517471 (10:72335449 C>A,T)
Disease associations
OMIM: gene MIM:608376 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006291_8 | Spherical equivalent or myopia (age of diagnosis) | 2.000000e-08 |
| GCST010002_290 | Refractive error | 2.000000e-17 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004847 | age at onset |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL6066345 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
ChEMBL bioactivities
2 potent at pChembl≥5 of 2 total, top 2 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 9.09 | Kd | 0.81 | nM | CHEMBL5653589 |
| 9.09 | ED50 | 0.81 | nM | CHEMBL5653589 |
PubChem BioAssay actives
1 with measured affinity, of 2 total; 1 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.
| Compound | Assay | Type | Value | Unit |
|---|---|---|---|---|
| 4-methyl-3-[(2-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide | 2148251: Binding affinity to human DNAJB12 incubated for 45 mins by Kinobead based pull down assay | kd | 0.0008 | uM |
CTD chemical–gene interactions
23 total (human), top 23 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases methylation, increases expression, decreases expression | 4 |
| Valproic Acid | affects expression, decreases expression, increases expression, increases methylation | 3 |
| aristolochic acid I | decreases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| titanium dioxide | decreases methylation | 1 |
| trichostatin A | affects expression | 1 |
| cobaltous chloride | decreases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| entinostat | increases expression | 1 |
| nutlin 3 | affects cotreatment, increases secretion | 1 |
| bisphenol B | increases expression | 1 |
| Vorinostat | decreases expression | 1 |
| Amiodarone | increases expression | 1 |
| Arsenic | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Dactinomycin | affects cotreatment, increases secretion | 1 |
| Piroxicam | increases expression, affects cotreatment | 1 |
| Smoke | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5651293 | Binding | Binding affinity to human DNAJB12 incubated for 45 mins by Kinobead based pull down assay | NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): refractive error